Your browser doesn't support javascript.
loading
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα.
Edelman-Klapper, Hadar; Zittan, Eran; Bar-Gil Shitrit, Ariella; Rabinowitz, Keren Masha; Goren, Idan; Avni-Biron, Irit; Ollech, Jacob E; Lichtenstein, Lev; Banai-Eran, Hagar; Yanai, Henit; Snir, Yifat; Pauker, Maor H; Friedenberg, Adi; Levy-Barda, Adva; Segal, Arie; Broitman, Yelena; Maoz, Eran; Ovadia, Baruch; Golan, Maya Aharoni; Shachar, Eyal; Ben-Horin, Shomron; Perets, Tsachi-Tsadok; Ben Zvi, Haim; Eliakim, Rami; Barkan, Revital; Goren, Sophy; Navon, Michal; Krugliak, Noy; Werbner, Michal; Alter, Joel; Dessau, Moshe; Gal-Tanamy, Meital; Freund, Natalia T; Cohen, Dani; Dotan, Iris.
Afiliação
  • Edelman-Klapper H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Zittan E; The Abraham and Sonia Rochlin IBD Unit, Department of Gastroenterology, Emek Medical Center, Afula, Israel; Rappaport Faculty of Medicine Technion-Israel Institute of Technology, Haifa, Israel.
  • Bar-Gil Shitrit A; Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Rabinowitz KM; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Felsenstein Medical Research Center, Sackler School of Medicine, Tel Aviv, Israel.
  • Goren I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Avni-Biron I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ollech JE; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Lichtenstein L; Clalit Health Services, Petah Tikva, Israel.
  • Banai-Eran H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Yanai H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Snir Y; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Pauker MH; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Friedenberg A; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
  • Levy-Barda A; Biobank, Department of Pathology, Rabin Medical Center, Petah Tikva, Israel.
  • Segal A; The Institute of Gastroenterology and Hepatology, Soroka University Medical Center, Beer-Sheva, Israel.
  • Broitman Y; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Maoz E; Clalit Health Services, Tel Aviv, Israel.
  • Ovadia B; Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel.
  • Golan MA; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shachar E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel.
  • Ben-Horin S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel.
  • Perets TT; Gastroenterology Laboratory, Division of Gastroenterology, Rabin Medical Center, Israel; Adelson School of Medicine, Ariel University, Ariel, Israel.
  • Ben Zvi H; Microbiology Lab, Rabin Medical Center, Petah Tikva, Israel.
  • Eliakim R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel.
  • Barkan R; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
  • Goren S; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Navon M; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Krugliak N; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Werbner M; Molecular Virology Lab, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Alter J; The Laboratory of Structural Biology of Infectious Diseases, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Dessau M; The Laboratory of Structural Biology of Infectious Diseases, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Gal-Tanamy M; Molecular Virology Lab, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Freund NT; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Cohen D; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Dotan I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: irisdo@clalit.org.il.
Gastroenterology ; 162(2): 454-467, 2022 02.
Article em En | MEDLINE | ID: mdl-34717923

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Imunogenicidade da Vacina / Inibidores do Fator de Necrose Tumoral / COVID-19 / Vacina BNT162 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Imunogenicidade da Vacina / Inibidores do Fator de Necrose Tumoral / COVID-19 / Vacina BNT162 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article